About
Paul Hung is a scientist-entrepreneur trained in Bioengineering at UC Berkeley with more than two decades of experience in life sciences. He co-founded CellASIC, which developed the ONIX microfluidic live-cell imaging platform and was acquired by MilliporeSigma (Merck KGaA), and later founded COMBiNATi, a digital PCR company acquired by Thermo Fisher Scientific in 2021. After running Thermo Fisher's global digital PCR business, he became CEO of Taudia, developing a blood-based biomarker platform for Alzheimer's and brain-health diagnostics.
Invests in
BiotechDigital HealthHealthtech
Experience
- TaudiaChief Executive Officercurrent2025 — presentSan Carlos, California, United States
- Live and LearnFree agentcurrent2024 — present
- Thermo Fisher ScientificSenior Director R&D (Emerging Technology)2024San Francisco Bay Area
- Thermo Fisher ScientificSenior Director and General Manager, Digital PCR2021 — 2024Palo Alto, California, United States
- CombinatiChief Executive Officer2016 — 2021Palo Alto, California, United States
- EMD MilliporeSenior R&D Manager2012 — 2016Hayward CA
- CellASIC CorporationChief Technology Offier2005 — 2012Hayward, CA
Skills & more
Microfluidics30Product Development25MEMS7Lifesciences2Matlab3Life Sciences23Medical Devices3Biotechnology12Cross-functional Team Leadership4Product Management2Biomedical Engineering3Cell Culture6
+12 more
CommercializationR&DCellMolecular BiologyCell BiologyLaboratoryTechnology TransferManufacturingLeadershipResearchProject ManagementResearch and Development (R&D)Languages English · Mandarin
From Paul's professional profile.
Colleagues at Endurance28
Carmiña De La Peña
Investor at Endurance28
Consuelo Valverde
Founder and Managing Partner at Endurance28
Cristina Mittermeier
Investor at Endurance28
Cynthia Cannady
Investor at Endurance28
Daniela Guerra
Investor at Endurance28
Garrett Dempsey
Investor at Endurance28
Jared Campbell
Investor at Endurance28
Jessica Chao
Investor at Endurance28
Frequently asked questions
- Who is Paul Hung?
- Paul Hung is a scientist-entrepreneur trained in Bioengineering at UC Berkeley with more than two decades of experience in life sciences. He co-founded CellASIC, which developed the ONIX microfluidic live-cell imaging platform and was acquired by MilliporeSigma (Merck KGaA), and later founded COMBiNATi, a digital PCR company acquired by Thermo Fisher Scientific in 2021. After running Thermo Fisher's global digital PCR business, he became CEO of Taudia, developing a blood-based biomarker platform for Alzheimer's and brain-health diagnostics.
- Where does Paul Hung work?
- Paul Hung is Venture Partner – Life Sciences at Endurance28.
- What does Paul Hung invest in?
- Paul Hung invests in Biotech, Digital Health, Healthtech.
- Where did Paul Hung go to school?
- Paul Hung studied at University of California, Berkeley (PhD, Electrical Engineering); National Taiwan University (Bachelor's degree, Electrical engineering).
Same school
Also attended University of California, Berkeley1,454
Byron DeeterPartner at Bessemer Venture PartnersSteve WozniakCo-founder of AppleTony XuCo-founder & CEO of DoorDashAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksRyan PetersenFounder & CEO of Flexport
+ 1,448 more
Also attended National Taiwan University68
Giorgio PastariniSenior Associate at P101 VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesJerry YangGeneral Partner at HCVCYannick RitschelInvestor at Backbone VenturesChristian GubaInvestor at Extantia Capital
+ 62 more
Shared employers
Also worked at Taudia1
Also worked at Thermo Fisher Scientific33
Thanasis DelistathisCo-Founder, Managing Partner at PROOFSean AinsworthBiotech CEO at FemHealth VenturesLu WangInvestor at Foothill VenturesSteven BohnFinancial Controller at Partech VenturesJohannes ClaussSerial Entrepreneur, Investor and Mentor at tokentus investment AGRolando BrawerExecutives in Residence at GENERAL INCEPTION
+ 27 more
